Senescent cells promote NAD tissue decline during aging through CD38 enzymes which can now become a novel therapeutic target. Nicotinamide …
Continue reading “NAD boosting to reverse senescence and inflammaging”
Avenna claims the first reliable, quantitative biomarkers for subclinical systemic chronic inflammation. Using the science of glycomics, British start-up Avenna …
Keystone Bio seeks funding as it gears up for clinical trials of therapeutic targeting the “keystone pathogen” of chronic inflammaging. …
Continue reading “Targeting inflammaging: the hidden “inflammapath” inside us”
Neurodegenerative disease is associated with age-related chronic, low grade inflammation, but studies suggest that this could be reversed with over …
Continue reading “Inflammaging – could ibuprofen be the answer?”
One of the largest deals in Irish biotech history sees Roche gain rights to full Inflazome portfolio. The Swiss company …
Continue reading “Inflammaging biotech acquired by Roche for €380m”
Researchers use metformin to repair broken cell machinery and drastically lower dangerous inflammation. Inflammaging is one of the latest Longevity …
Continue reading “Metformin boost for inflammaging research”
Defining longevity isn’t straightforward; to get there we must negotiate its determinants, drivers and diseases. If you ask someone what …
Gorbunova Aging Research Center team is encouraged by frailty results from SIRT6 activator trial. SIRT6, the so-called “longevity sirtuin” has …
Continue reading “Longevity sirtuin clinical trial teases promising results”
Longeveron’s Dr Joshua Hare talks frailty, Alzheimer’s and cell therapy clinical trials. Longeveron is a clinical-stage biotechnology company developing cellular …
